Literature DB >> 25287259

Hyperglycemia and insulin resistance and the risk of BPH/LUTS: an update of recent literature.

Benjamin N Breyer1, Aruna V Sarma.   

Abstract

Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) are highly prevalent in older men and represent a substantial challenge to public health. Increasing epidemiologic evidence suggests that diabetes and associated hyperglycemia and insulin resistance significantly increase the risks of BPH and LUTS. Plausible pathophysiologic mechanisms to explain these associations include increased sympathetic tone, stimulation of prostate growth by insulin and related trophic factors, alterations in sex steroid hormone expression, and induction of systemic inflammation and oxidative stress. This article presents a comprehensive update of the current understanding of clinical and epidemiologic research on diabetes and BPH/LUTS, describes hypothesized pathophysiologic mechanisms linking these conditions, and recommends future directions for research.

Entities:  

Mesh:

Year:  2014        PMID: 25287259      PMCID: PMC4527683          DOI: 10.1007/s11934-014-0462-x

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  36 in total

1.  Prostate volume correlates with diabetes in elderly benign prostatic hyperplasia patients.

Authors:  Xiaobing Qu; Zhichao Huang; Xianqin Meng; Xiangyu Zhang; Lini Dong; Xiaokun Zhao
Journal:  Int Urol Nephrol       Date:  2014-03       Impact factor: 2.370

2.  Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction.

Authors:  Debra E Irwin; Zoe S Kopp; Barnabie Agatep; Ian Milsom; Paul Abrams
Journal:  BJU Int       Date:  2011-01-13       Impact factor: 5.588

3.  Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation.

Authors:  Linda Vignozzi; Mauro Gacci; Ilaria Cellai; Raffaella Santi; Giovanni Corona; Annamaria Morelli; Giulia Rastrelli; Paolo Comeglio; Arcangelo Sebastanelli; Elena Maneschi; Gabriella Nesi; Cosimo De Nunzio; Andrea Tubaro; Edoardo Mannucci; Marco Carini; Mario Maggi
Journal:  Prostate       Date:  2012-11-28       Impact factor: 4.104

4.  The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.

Authors:  Karin S Coyne; Chris C Sexton; Debra E Irwin; Zoe S Kopp; Con J Kelleher; Ian Milsom
Journal:  BJU Int       Date:  2008-06       Impact factor: 5.588

Review 5.  Diabetes and benign prostatic hyperplasia: emerging clinical connections.

Authors:  Aruna V Sarma; J Kellogg Parsons
Journal:  Curr Urol Rep       Date:  2009-07       Impact factor: 3.092

6.  Hyperglycemia, hyperinsulinemia, insulin resistance, and the risk of BPH/LUTS severity and progression over time in community dwelling black men: the Flint Men's Health Study.

Authors:  Lauren P Wallner; John M Hollingsworth; Rodney L Dunn; Catherine Kim; William H Herman; Aruna V Sarma
Journal:  Urology       Date:  2013-07-31       Impact factor: 2.649

7.  Type 2 diabetes but not metabolic syndrome is associated with an increased risk of lower urinary tract symptoms and erectile dysfunction in men aged <45 years.

Authors:  Chung Cheng Wang; Michael B Chancellor; Jyh Ming Lin; Jui Hsiang Hsieh; Hong Jeng Yu
Journal:  BJU Int       Date:  2009-10-05       Impact factor: 5.588

8.  Insulin resistance is an independent predictor of severe lower urinary tract symptoms and of erectile dysfunction: results from a cross-sectional study.

Authors:  Giorgio Ivan Russo; Sebastiano Cimino; Eugenia Fragalà; Salvatore Privitera; Sandro La Vignera; Rosita Condorelli; Aldo E Calogero; Tommaso Castelli; Vincenzo Favilla; Giuseppe Morgia
Journal:  J Sex Med       Date:  2014-05-19       Impact factor: 3.802

9.  Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.

Authors:  Nora E Straznicky; Mariee T Grima; Carolina I Sari; Nina Eikelis; Elisabeth A Lambert; Paul J Nestel; Murray D Esler; John B Dixon; Reena Chopra; Alan J Tilbrook; Markus P Schlaich; Gavin W Lambert
Journal:  Diabetes       Date:  2012-06-04       Impact factor: 9.461

10.  Stromal insulin-like growth factor binding protein 3 (IGFBP3) is elevated in the diseased human prostate and promotes ex vivo fibroblast-to-myofibroblast differentiation.

Authors:  Natalie Sampson; Christoph Zenzmaier; Martin Heitz; Martin Hermann; Eugen Plas; Georg Schäfer; Helmut Klocker; Peter Berger
Journal:  Endocrinology       Date:  2013-05-29       Impact factor: 4.736

View more
  16 in total

Review 1.  The good, the bad, and the ugly facets of insulin resistance.

Authors:  K V S Hari Kumar
Journal:  Med J Armed Forces India       Date:  2020-01-06

2.  Are blood vessels a target to treat lower urinary tract dysfunction?

Authors:  Martin C Michel; Russ Chess-Williams; Sharath S Hegde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-05-31       Impact factor: 3.000

3.  Probable Tamsulosin-Induced Hyperglycemia: A Case Study.

Authors:  Stefanie C Nigro; Ryan Nolan; Nicholas Boemio
Journal:  Clin Diabetes       Date:  2022-01

4.  The association of new-onset diabetes mellitus and medical therapy for benign prostatic hyperplasia: A population-based study.

Authors:  Jeannette Johnstone; Avril Lusty; Mina Tohidi; Marlo Whitehead; Joan Tranmer; J Curtis Nickel; D Robert Siemens
Journal:  Can Urol Assoc J       Date:  2021-08       Impact factor: 1.862

5.  NF-κB and androgen receptor variant expression correlate with human BPH progression.

Authors:  David C Austin; Douglas W Strand; Harold L Love; Omar E Franco; Alex Jang; Magdalena M Grabowska; Nicole L Miller; Omar Hameed; Peter E Clark; Jay H Fowke; Robert J Matusik; Ren J Jin; Simon W Hayward
Journal:  Prostate       Date:  2015-12-28       Impact factor: 4.104

6.  A folic acid-enriched diet attenuates prostate involution in response to androgen deprivation.

Authors:  Diya B Joseph; Anoop S Chandrashekar; Li-Fang Chu; James A Thomson; Chad M Vezina
Journal:  Prostate       Date:  2018-10-08       Impact factor: 4.104

7.  High glucose induces the proliferation of prostatic cells via downregulating MRE11.

Authors:  Chunwei Ye; Yi Cai; Qian Cai; Shunhui Yuan; Fan Huang; Xiaofang Yang; Shuchen He; Zhuoheng Li; Yanwen Wang; Delin Yang; Zhipeng Li
Journal:  Int J Mol Med       Date:  2018-03-07       Impact factor: 4.101

8.  The Roles of ZnT1 and ZnT4 in Glucose-Stimulated Zinc Secretion in Prostate Epithelial Cells.

Authors:  Su-Tang Lo; Daniel Parrott; M Veronica Clavijo Jordan; Diya Binoy Joseph; Douglas Strand; U-Ging Lo; Ho Lin; Anza Darehshouri; A Dean Sherry
Journal:  Mol Imaging Biol       Date:  2020-11-02       Impact factor: 3.488

9.  High-Fat Diet Induced Gut Microbiota Alterations Associating With Ghrelin/Jak2/Stat3 Up-Regulation to Promote Benign Prostatic Hyperplasia Development.

Authors:  Meng Gu; Chong Liu; TianYe Yang; Ming Zhan; Zhikang Cai; Yanbo Chen; Qi Chen; Zhong Wang
Journal:  Front Cell Dev Biol       Date:  2021-06-24

10.  Diabetes in the hospitalized patients with urological diseases.

Authors:  I Verde; E Rusu; E Suliman; A Costache; P Armean
Journal:  J Med Life       Date:  2015 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.